Search

everythinglearnresearchcommunity

for

Search:↓

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

People with pattern hair loss have higher polyamine levels in the top of their head compared to the back.

Specialized ribosomes affect aging in human skin cells.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Skin abnormalities can indicate immunodeficiency due to shared origins with the immune system.

TNF-alpha inhibitors can cause various immune-related skin issues.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.